Why the study?
Does treatment of mild hypertension (diastolic BP 95-109 mm Hg) provide clinical benefit?
Does treatment of mild hypertension (diastolic BP 95-109 mm Hg) provide clinical benefit?
Answers are grounded in this paper and cite their sources.
Methodological flaws, specifically selection bias from classifying by attained blood pressure, invalidate retrospective claims that treating mild hypertension is ineffective or harmful.
Despite the clear-cut result of the Australian Therapeutic Trial in Mild Hypertension, which demonstrated prospectively the benefit of treatment of diastolic blood pressure in the range of 95 to 109 mm Hg, a retrospective analysis that classified subjects by the average diastolic pressure level attained during the trial purported to show an absence of treatment benefit at lower average diastolic pressures and a negative treatment effect at higher levels. However, the method of classification by average attained diastolic pressure introduced substantial selection bias, invalidating the retrospective analysis and rendering as spurious both the deleterious treatment effect and its lack of efficacy at lower diastolic levels.
No takes yet. Share an insight, caveat, or question.
John Abernethy (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: